Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3953400rdf:typepubmed:Citationlld:pubmed
pubmed-article:3953400lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0031001lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0155626lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0033141lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0242698lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0035253lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:3953400lifeskim:mentionsumls-concept:C0303322lld:lifeskim
pubmed-article:3953400pubmed:issue4lld:pubmed
pubmed-article:3953400pubmed:dateCreated1986-4-18lld:pubmed
pubmed-article:3953400pubmed:abstractTextThis study examined the value of resting thallium-201 imaging in differentiating patients with primary cardiomyopathy from those with ischemic cardiomyopathy. There were 15 patients with primary cardiomyopathy (group I); 20 with chronic CAD (group II); and 25 with acute Q wave myocardial infarction (group III). All patients had LVEF less than or equal to 35%. The thallium score was less than 50 (maximum 60) in one patient (7%) in group I, in 17 patients (85%) in group II, and in 25 patients (100%) in group III (p less than 0.0001, I vs II and III). The number of normal segments was 11.4 +/- 4.9 in group I, 6.9 +/- 2.9 in group II, and 7.0 +/- 2.2 in group III (p less than 0.0001, I vs II, III). Reversible defects were present in three patients in group II, three in group III, and none in group I. Abnormal right ventricular thallium uptake was observed in 27% of patients in group I, 25% in group II, and 40% in group III (p = NS). Abnormal lung thallium uptake was observed in 33% in group I, 20% in group II, and 20% in group III (p = NS). Thus, rest thallium imaging is useful in separating patients with primary cardiomyopathy from those with ischemic cardiomyopathy.lld:pubmed
pubmed-article:3953400pubmed:languageenglld:pubmed
pubmed-article:3953400pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953400pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3953400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953400pubmed:statusMEDLINElld:pubmed
pubmed-article:3953400pubmed:monthAprlld:pubmed
pubmed-article:3953400pubmed:issn0002-8703lld:pubmed
pubmed-article:3953400pubmed:authorpubmed-author:IskandrianA...lld:pubmed
pubmed-article:3953400pubmed:authorpubmed-author:HakkiA HAHlld:pubmed
pubmed-article:3953400pubmed:authorpubmed-author:KannHHlld:pubmed
pubmed-article:3953400pubmed:issnTypePrintlld:pubmed
pubmed-article:3953400pubmed:volume111lld:pubmed
pubmed-article:3953400pubmed:ownerNLMlld:pubmed
pubmed-article:3953400pubmed:authorsCompleteYlld:pubmed
pubmed-article:3953400pubmed:pagination760-7lld:pubmed
pubmed-article:3953400pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:meshHeadingpubmed-meshheading:3953400-...lld:pubmed
pubmed-article:3953400pubmed:year1986lld:pubmed
pubmed-article:3953400pubmed:articleTitleResting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction.lld:pubmed
pubmed-article:3953400pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3953400pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3953400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3953400lld:pubmed